TRIDENTII HEMI CLUSTER48D-indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 702-11-48D
Published May 1, 2024 · Recall initiated: February 27, 2024
Summary
FDA records medical device Class II recall Z-1622-2024, published May 1, 2024 and initiated February 27, 2024. Recalling firm: Howmedica Osteonics Corp.; Status: Ongoing; Reported quantity: 45 units; Lot: UDI-DI: (01)07613327380903(17)290313(10) Lot Number: 14875651 15005253 16044255. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Howmedica Osteonics Corp.
- Distributor
- Nationwide Foreign: Netherlands, Canada, Singapore, Spain, Sweden, UK
- Lot
- UDI-DI: (01)07613327380903(17)290313(10) Lot Number: 14875651 15005253 16044255
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATS Femoral Prep Tray, Triathlon. Catalog Number: 6543-6-507.October 21, 2026
- FDATriathlon Hinge Femoral Prep Tray. Catalog Number: 6543-6-514.October 21, 2026
- FDATS Universal Baseplate Finishing Tray, Triathlon. Catalog Number: 6543-6-506.October 21, 2026
- FDATS Misc. Instruments Tray, Triathlon. Catalog Number: 6543-6-519.October 21, 2026
- FDATRIDENTII HEMI CLUSTER44B- Indicated for use in primary and revision patients at high risk of hip dislocationMay 1, 2024
- FDATRIDENTII HEMI CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocationMay 1, 2024
Questions about this recall
Was TRIDENTII HEMI CLUSTER48D-indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 702-11-48D recalled?
Yes. FDA published recall Z-1622-2024 on May 1, 2024. Reported hazard: The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell
What should I do if I have this product?
Voluntary: Firm initiated · Letter